Edesa Biotech, Inc. — Director's Dealing 2018

Oct 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Stellar Biotechnologies, Inc. (SBOT)
CIK: 0001540159
Period of Report: 2018-10-12

Reporting Person: MORSE DANIEL E. (Former Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-12	Common Shares, without par value	S	7047	$1.314	Disposed	20741	Direct

Footnotes

F1: The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.